Document Detail

Cord pilot trial - immediate versus deferred cord clamping for very preterm birth (before 32 weeks gestation): study protocol for a randomized controlled trial.
MedLine Citation:
PMID:  24981366     Owner:  NLM     Status:  Publisher    
BACKGROUND: Preterm birth is the most important single determinant of adverse outcome in the United Kingdom; one in every 70 babies (1.4%) is born before 32 weeks (very preterm), yet these births account for over half of infant deaths.Deferring cord clamping allows blood flow between baby and placenta to continue for a short time. This often leads to increased neonatal blood volume at birth and may allow longer for transition to the neonatal circulation. Optimal timing for clamping the cord remains uncertain, however. The Cochrane Review suggests that deferring umbilical cord clamping for preterm births may improve outcome, but larger studies reporting substantive outcomes and with long-term follow-up are needed. Studies of the physiology of placental transfusion suggest that flow in the umbilical cord at very preterm birth may continue for several minutes. This pilot trial aims to assess the feasibility of conducting a large randomised trial comparing immediate and deferred cord clamping in the UK.
METHODS: Women are eligible for the trial if they are expected to have a live birth before 32 weeks gestation. Exclusion criteria are known monochorionic twins or clinical evidence of twin-twin transfusion syndrome, triplet or higher order multiple pregnancy, and known major congenital malformation. The interventions will be cord clamping within 20 seconds compared with cord clamping after at least two minutes. For births with cord clamping after at least two minutes, initial neonatal care is at the bedside. For the pilot trial, outcomes include measures of recruitment, compliance with the intervention, retention of participants and data quality for the clinical outcomes.Information about the trial is available to women during their antenatal care. Women considered likely to have a very preterm birth are approached for informed consent. Randomisation is close to the time of birth. Follow-up for the women is for one year, and for the children to two years of age (corrected for gestation at birth). The target sample size is 100 to 110 mother-infant pairs recruited over 12 months at eight sites.Trial registration: ISRCTN21456601, registered on 28 February 2013.
Angela Pushpa-Rajah; Lucy Bradshaw; Jon Dorling; Gill Gyte; Eleanor J Mitchell; Jim Thornton; Lelia Duley
Related Documents :
19436436 - Preparing for the first birth: mothers' experiences at home and in hospital in australia.
22295036 - Accuracy of sonographic criteria in the decision for surgical treatment in infantile hy...
21324046 - Defining awakening from anesthesia in neonates: a consensus study.
14569146 - Sex differentiation and pubertal development of gonads in the viviparous mosquitofish, ...
2078976 - Influence of gestational age on pharmacokinetics of alfentanil in neonates.
20335626 - Neither a zinc supplement nor phytate-reduced maize nor their combination enhance growt...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-30
Journal Detail:
Title:  Trials     Volume:  15     ISSN:  1745-6215     ISO Abbreviation:  Trials     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-7-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101263253     Medline TA:  Trials     Country:  -    
Other Details:
Languages:  ENG     Pagination:  258     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diel periodicity of pheromone release by females of Planococcus citri and Planococcus ficus and the ...
Next Document:  A comprehensive analysis of piRNAs from adult human testis and their relationship with genes and mob...